Department of Design, Housing, and Apparel, College of Design, University of Minnesota, Twin Cities Campus, St. Paul, MN 55108, USA.
HERD. 2009 Spring;2(3):29-50. doi: 10.1177/193758670900200303.
This paper discusses the integration of evidence-based design (EBD) into the design process as an innovation, illuminates the significance and progress of the diffusion of this innovation, and identifies EBD advocates and the consequences of meeting the EBD challenge. A free tool for engaging in EBD is explored. Healthcare designers are leading the EBD charge, because their clients depend on it. But not all designers engage in EBD, because it may be beyond the resources of a firm or outside its culture. However, as with other meaningful design innovations, designers who do not practice EBD could fall by the wayside. EBD is a product of the diffusion of the innovation of evidence-based medicine. The academy (i.e., the collective of institutions of higher education), design organizations, design communities, and the media all contribute to the diffusion of EBD. However, the quantity, quality, and understandability of evidence continue to challenge its broad adoption. InformeDesign®, a free, Internet-based tool, presents information to designers in a concise, understandable way. Firms must invest in EBD incrementally as a value-added component of design to meet current and future challenges. It is important for designers to realize that engaging in EBD is not a rejection of creativity, but a means by which to elevate their design solutions.
本文探讨了循证设计（EBD）作为一种创新融入设计过程的问题，阐明了这一创新扩散的意义和进展，并确定了 EBD 的倡导者以及应对 EBD 挑战的结果。还探讨了一种参与 EBD 的免费工具。医疗保健设计师正在引领 EBD 的发展，因为他们的客户依赖于它。但并非所有设计师都参与 EBD，因为这可能超出了公司的资源或超出了其文化范围。然而，与其他有意义的设计创新一样，不实践 EBD 的设计师可能会被淘汰。EBD 是循证医学创新扩散的产物。学术界（即高等教育机构的集体）、设计组织、设计社区和媒体都为 EBD 的扩散做出了贡献。然而，证据的数量、质量和可理解性仍然对其广泛采用构成挑战。免费的基于互联网的工具“InformeDesign®”以简洁易懂的方式向设计师呈现信息。公司必须逐步投资 EBD，将其作为设计的增值组件，以应对当前和未来的挑战。设计师必须认识到，参与 EBD 不是对创造力的否定，而是提升设计解决方案的一种手段。
